LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Key Hires Engitix has made strategic appointments of experienced professionals like Matthew Edwards, Emma Huang, and Christopher Stevenson, indicating a potential increase in focus on research and development efforts. Leveraging these new talents can open doors to collaborative opportunities with industry leaders.

Facility Expansion The recent expansion of Engitix's facilities in London suggests a growth in operational capacity. This enhanced infrastructure can be used to attract new partnerships, drive innovation, and accommodate larger production volumes, presenting an ideal opportunity for scaling sales initiatives.

Partnership with Takeda Engitix's partnership with Takeda, specifically in the field of inflammatory bowel disease, showcases the company's ability to form strategic collaborations with established pharmaceutical giants. This collaboration can serve as a reference point to engage with other prominent players in the industry.

Board of Directors Expansion The addition of industry experts like Mike Platt and Gianluca Rossetti to Engitix's board of directors enhances the company's industry credibility and network. Leveraging the connections and insights of these influential figures can create new pathways for sales growth and business development.

Unique Technology Platform Engitix's pioneering human extracellular matrix-based discovery platform offers a distinct competitive advantage in drug discovery. Highlighting the efficacy and uniqueness of this technology can attract pharmaceutical companies seeking innovative solutions, positioning Engitix as a strategic partner for joint ventures and licensing opportunities.

Similar companies to Engitix Therapeutics

Engitix Therapeutics Tech Stack

Engitix Therapeutics uses 8 technology products and services including Google Font API, jQuery, Google, and more. Explore Engitix Therapeutics's tech stack below.

  • Google Font API
    Font Scripts
  • jQuery
    Javascript Libraries
  • Google
    Miscellaneous
  • RSS
    Miscellaneous
  • Python
    Programming Languages
  • JavaScript
    Programming Languages
  • YouTube
    Video Players
  • Apache HTTP Server
    Web Servers

Media & News

Engitix Therapeutics's Email Address Formats

Engitix Therapeutics uses at least 1 format(s):
Engitix Therapeutics Email FormatsExamplePercentage
First.Last@engitix.comJohn.Doe@engitix.com
48%
First.Middle@engitix.comJohn.Michael@engitix.com
2%
First.Last@engitix.comJohn.Doe@engitix.com
48%
First.Middle@engitix.comJohn.Michael@engitix.com
2%

Frequently Asked Questions

Where is Engitix Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Engitix Therapeutics's main headquarters is located at 21 Lombard Street London, England EC3V 9AH GB. The company has employees across 2 continents, including EuropeNorth America.

What is Engitix Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Engitix Therapeutics's official website is engitix.com and has social profiles on LinkedIn.

How much revenue does Engitix Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Engitix Therapeutics's annual revenue reached $15M.

What is Engitix Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Engitix Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Engitix Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Engitix Therapeutics has approximately 51 employees across 2 continents, including EuropeNorth America. Key team members include Vice President Fibrosis: A. H.Co-Founder And Ceo: G. M.Co-Founder And Consultant Engitix Theraputics Ltd, London, Uk: M. P.. Explore Engitix Therapeutics's employee directory with LeadIQ.

What industry does Engitix Therapeutics belong to?

Minus sign iconPlus sign icon
Engitix Therapeutics operates in the Biotechnology Research industry.

What technology does Engitix Therapeutics use?

Minus sign iconPlus sign icon
Engitix Therapeutics's tech stack includes Google Font APIjQueryGoogleRSSPythonJavaScriptYouTubeApache HTTP Server.

What is Engitix Therapeutics's email format?

Minus sign iconPlus sign icon
Engitix Therapeutics's email format typically follows the pattern of . Find more Engitix Therapeutics email formats with LeadIQ.

How much funding has Engitix Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Engitix Therapeutics has raised $54M in funding. The last funding round occurred on Jan 19, 2022 for $54M.

When was Engitix Therapeutics founded?

Minus sign iconPlus sign icon
Engitix Therapeutics was founded in 2016.
Engitix Therapeutics

Engitix Therapeutics

Biotechnology ResearchEngland, United Kingdom51-200 Employees

To create a healthier future for patients with life-threatening diseases, we are using our pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumours.
Using human in vitro models that better recreate the natural cell microenvironment is transforming our ability to identify new targets, determine mechanisms of action, and increase the success rate of therapeutic candidates.
We have pioneered the world’s first human extracellular matrix-based discovery platform to aid in the discovery of targets and biomarkers as well as drug profiling.  Using our technology, we have a unique ability to study tissue- and disease-specific human ECM scaffolds, and to model diseases to study mechanisms of action. Our improved understanding of the role of the ECM in human enables the identification of more relevant drug targets and biomarkers. For drug discovery, we incorporate human ECM into our in vitro models, thereby recreating the natural cell microenvironment so that drug candidates can be tested in the context they will ultimately be used in. With the potential to predict the efficacy of candidates more accurately at an earlier stage, the platform can reduce late-stage clinical failures and accelerate discovery.

Section iconCompany Overview

Headquarters
21 Lombard Street London, England EC3V 9AH GB
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $54M

    Engitix Therapeutics has raised a total of $54M of funding over 2 rounds. Their latest funding round was raised on Jan 19, 2022 in the amount of $54M.

  • $10M$50M

    Engitix Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $54M

    Engitix Therapeutics has raised a total of $54M of funding over 2 rounds. Their latest funding round was raised on Jan 19, 2022 in the amount of $54M.

  • $10M$50M

    Engitix Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.